On April, 8 this year the reputable international rating The Legal 500 Europe, Middle East & Africa published the results of legal markets research in 2015. Thus, four Partners and the Counsel of Legal Alliance Company were rewarded as the most recommendable Ukrainian lawyers in intellectual property and corporate law.
The analytics of this research in the third time marked achievements of Partner and Patent attorney Illia Kostin in intellectual property, who was reminded as an excellent expert in his sphere. This year in this practice, Associated Partner Andriy Gorbatenko and Counsel Natalia Lavrenova were awarded, in particular, in the area of pharmacy.
In their turn, Partner Oleksii Bezevets and Partner Dmytro Aleshko were included in the list of leading experts in the corporate law. The analysts notice the high professional level of the team, which realized the range of projects on pharmaceutical business reorganization.
It should be reminded, that The Legal 500 EMEA – one of the most reputable international legal publication, established in 1988. The assessments and recommendations of this guide are based on independent researches, law firm questionnaire, clients and partners polling. The handbook gives the most extensive and accurate information about law firms from more than 100 countries. Such independent rating estimations aim to help foreign law firms and heads of legal departments to find the leading law companies and experts in different practices. The companies included in the rating are divided in tiers in accordance with the quantity and quality of realized projects for report period. For example, the scope, the difficulty and the project significancy for certain area are estimated, as well as the dealing cost and reputation of engaged lawyers.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
